
Opinion|Videos|November 8, 2024
Unmet Needs in Generalized Myasthenia Gravis
Key Takeaways
- Current MG treatments often have limited efficacy and significant side effects, necessitating more effective and targeted therapies.
- Early and accurate diagnosis is crucial, highlighting the need for better diagnostic tools in MG management.
Panelists discuss how certain aspects of myasthenia gravis management remain challenging, identifying ongoing unmet needs in diagnosis, treatment, and patient care.
Advertisement
Video content above is prompted by the following:
- What continue to be unmet needs in myasthenia gravis?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Approves Tau PET Tracer MK-6240 for Alzheimer Diagnostic Workup
2
FDA Clears Phase 2 Trial for Demyelinating Agent Lucid-MS in Progressive Multiple Sclerosis
3
Ractigen Completes Enrollment for RAG-17 in SOD1-ALS, Tanruprubart Shows Rapid Responses in GBS, Building a Multidisciplinary SMA Clinic
4
CN045 Promotes Oligodendrocyte Maturation, Modest Remyelination in Preclinical MS Study
5











